EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells

Lauria Claeys, Lidiia Zhytnik iD, Laura Ventura, Lisanne E Wisse, Elisabeth M W Eekhoff iD, Gerard Pals iD, Nathalie Bravenboer, Vivi M Heine iD, Dimitra Micha

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lauria Claeys und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Estonian Research Council, Horstingstuit foundation, kind donation of Hans Horsting and Mary Horsting-Stuit of the Horstingstuit Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) Mesenchymal stem cells (MSCs) are a valuable cell model to study the bone pathology of Osteogenesis Imperfecta (OI), a rare genetic collagen-related disorder characterized by bone fragility and skeletal dysplasia. We aimed to generate a novel OI induced mesenchymal stem cell (iMSC) model from induced pluripotent stem cells (iPSCs) derived from human dermal fibroblasts. For the first time, OI iMSCs generation was based on an intermediate neural crest cell (iNCC) stage. (2) Skin fibroblasts from healthy individuals and OI patients were reprogrammed into iPSCs and subsequently differentiated into iMSCs via iNCCs. (3) Successful generation of iPSCs from acquired fibroblasts was confirmed with changes in cell morphology, expression of iPSC markers SOX2, NANOG, and OCT4 and three germ-layer tests. Following differentiation into iNCCs, cells presented increased iNCC markers including P75NTR, TFAP2A, and HNK-1 and decreased iPSC markers, shown to reach the iNCC stage. Induction into iMSCs was confirmed by the presence of CD73, CD105, and CD90 markers, low expression of the hematopoietic, and reduced expression of the iNCC markers. iMSCs were trilineage differentiation-competent, confirmed using molecular analyses and staining for cell-type-specific osteoblast, adipocyte, and chondrocyte markers. (4) In the current study, we have developed a multipotent in vitro iMSC model of OI patients and healthy controls able to differentiate into osteoblast-like cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaMesenchymal Stem CellsInduced Pluripotent Stem CellsHumansCell DifferentiationCollagenSkinOsteogenesis

Stichwörter der Autor:innen

Osteogenesis Imperfectabonecell modelinduced mesenchymal stem cellsosteoblastskeletal dysplasia

Substanzen

Collagen

Autor:innen und Institutionen

  • Department of Human Genetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Rare Bone Disease Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Amsterdam Movement Sciences, 1081 HV Amsterdam, The Netherlands.
  • Amsterdam Reproduction and Development, 1081 HV Amsterdam, The Netherlands.
  • Department of Traumatology and Orthopaedics, The University of Tartu, 50410 Tartu, Estonia.
  • Department of Endocrinology and Metabolism, Amsterdam UMC Location Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.

ORCID-Profile: Lidiia Zhytnik, Elisabeth M W Eekhoff, Gerard Pals, Vivi M Heine

Förderung

  • Estonian Research Council
  • Horstingstuit foundation
  • kind donation of Hans Horsting and Mary Horsting-Stuit of the Horstingstuit Foundation

Zitieren

APA

Claeys, L., Zhytnik, L., Ventura, L., Wisse, L. E., Eekhoff, E. M. W., Pals, G., Bravenboer, N., Heine, V. M., & Micha, D. (2024). In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063417

Vancouver

Claeys L, Zhytnik L, Ventura L, Wisse LE, Eekhoff EMW, Pals G, et al. In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063417

BibTeX
@article{Claeys2024,
  author = {Claeys, Lauria and Zhytnik, Lidiia and Ventura, Laura and Wisse, Lisanne E and Eekhoff, Elisabeth M W and Pals, Gerard and Bravenboer, Nathalie and Heine, Vivi M and Micha, Dimitra},
  title = {In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063417}
}
Kostenlos starten →